Upregulation of the Bcl-2 antiapoptotic proteins is a frequent method by which cancer cells can resist apoptosis since the Bcl-2 gene has a crucial role in controlling apoptosis in the initiation, progression, and resistance to targeted therapy of tumor [33]. This evidence concerns the gene BCL2 and cancer.